Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Teva
Cantor Fitzgerald
UBS
Colorcon

Generated: July 18, 2019

DrugPatentWatch Database Preview

Patent: 8,906,885

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,906,885
Title:Treating cancer with HSP90 inhibitory compounds
Abstract: Methods of treating cancer with a compound of formulae (I) or (1a) are disclosed. Also provided are methods of treating a cancer with a mutation in ALK or a c-MET mutation with a compound of formulae (I) or (1a). Further provided are methods of treating non-small cell lung cancer with a mutation in ALK with a compound of formulae (I) or (1a); a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables structural formulae are defined herein.
Inventor(s): El-Hariry; Iman (Boston, MA), Proia; David (Newton, MA), Vukovic; Vojo (Winchester, MA)
Assignee: Synta Pharmaceuticals Corp. (Lexington, MA)
Application Number:14/131,183
Patent Claims:see list of patent claims

Details for Patent 8,906,885

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial Synta Pharmaceuticals Corp. (Lexington, MA) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial Synta Pharmaceuticals Corp. (Lexington, MA) ➤ Try a Free Trial RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Try a Free Trial Synta Pharmaceuticals Corp. (Lexington, MA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Argus Health
McKesson
Fish and Richardson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.